These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Adiponectin in diabetes mellitus. Xita N; Tsatsoulis A Curr Med Chem; 2012; 19(32):5451-8. PubMed ID: 22876922 [TBL] [Abstract][Full Text] [Related]
26. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757 [TBL] [Abstract][Full Text] [Related]
27. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Yamauchi T; Kadowaki T Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982 [TBL] [Abstract][Full Text] [Related]
28. Post-translational modifications of adiponectin: mechanisms and functional implications. Wang Y; Lam KS; Yau MH; Xu A Biochem J; 2008 Feb; 409(3):623-33. PubMed ID: 18177270 [TBL] [Abstract][Full Text] [Related]
29. Dietary regulation of nuclear receptors in obesity-related metabolic syndrome. Kawada T; Goto T; Hirai S; Kang MS; Uemura T; Yu R; Takahashi N Asia Pac J Clin Nutr; 2008; 17 Suppl 1():126-30. PubMed ID: 18296319 [TBL] [Abstract][Full Text] [Related]
30. Recent insights on modulation of inflammasomes by adipokines: a critical event for the pathogenesis of obesity and metabolism-associated diseases. Pham DV; Park PH Arch Pharm Res; 2020 Oct; 43(10):997-1016. PubMed ID: 33078304 [TBL] [Abstract][Full Text] [Related]
31. Different molecular signaling sustaining adiponectin action in breast cancer. Panno ML; Naimo GD; Spina E; Andò S; Mauro L Curr Opin Pharmacol; 2016 Dec; 31():1-7. PubMed ID: 27552697 [TBL] [Abstract][Full Text] [Related]
32. Molecular mechanisms underlying the potential antiobesity-related diseases effect of cocoa polyphenols. Ali F; Ismail A; Kersten S Mol Nutr Food Res; 2014 Jan; 58(1):33-48. PubMed ID: 24259381 [TBL] [Abstract][Full Text] [Related]
33. Adiponectin, Obesity, and Cancer: Clash of the Bigwigs in Health and Disease. Parida S; Siddharth S; Sharma D Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31121868 [TBL] [Abstract][Full Text] [Related]
34. Relationship between adiponectin, obesity and insulin resistance. Balsan GA; Vieira JL; Oliveira AM; Portal VL Rev Assoc Med Bras (1992); 2015; 61(1):72-80. PubMed ID: 25909213 [TBL] [Abstract][Full Text] [Related]
35. Type 2 diabetes and cardiovascular disease: getting to the fat of the matter. Goralski KB; Sinal CJ Can J Physiol Pharmacol; 2007 Jan; 85(1):113-32. PubMed ID: 17487251 [TBL] [Abstract][Full Text] [Related]
36. Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications. Wang Y; Zhou M; Lam KS; Xu A Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):201-12. PubMed ID: 19466213 [TBL] [Abstract][Full Text] [Related]
37. The role of adiponectin in metabolic and vascular disease: a review. Cui J; Panse S; Falkner B Clin Nephrol; 2011 Jan; 75(1):26-33. PubMed ID: 21176748 [TBL] [Abstract][Full Text] [Related]
38. Adipocytokines and obesity-linked disorders. Ouchi N; Ohashi K; Shibata R; Murohara T Nagoya J Med Sci; 2012 Feb; 74(1-2):19-30. PubMed ID: 22515108 [TBL] [Abstract][Full Text] [Related]
39. Adipocytokines in relation to cardiovascular disease. Van de Voorde J; Pauwels B; Boydens C; Decaluwé K Metabolism; 2013 Nov; 62(11):1513-21. PubMed ID: 23866981 [TBL] [Abstract][Full Text] [Related]
40. Cyclolepis genistoides D. Don (palo azul) promotes differentiation of adipocytes and regulates adipokine expression. Sato H; Ishikawa M; Funaki A; Kimura Y; Yoshida H; Fukata H; Hasegawa H; Ueno K Nutr Res; 2013 Nov; 33(11):922-31. PubMed ID: 24176232 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]